Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canada Contact

Aliphatic Amines Group

These substances were identified for action under the Chemicals Management Plan (CMP). The screening assessment focuses on 13 substances referred to collectively under the CMP as the Aliphatic Amines Group. The ecological risk of the nine long-chain aliphatic amines identified in the table below was assessed using a class-based approach that encompasses a wider set of both monoamine and diamine substances, as detailed in the screening assessment. It includes but is not limited to the nine long-chain aliphatic amines identified in the table below.

Information sheet

Summary of publications
Substance group Subgroup CAS RN Common name and/or acronym DSL name Draft screening assessment Risk management scope Proposed conclusion on section 64 criteria Follow-up activities
Aliphatic Amines Group Short-chain 103-83-3Table 1 Footnote a Dimethylbenzylamine Benzenemethanamine, N, N-dimethyl- HTML None Does not meet None planned at this time
107-15-3 Ethylenediamine 1,2-Ethanediamine
111-40-0 Diethylenetriamine 1,2-Ethanediamine, N-(2-aminoethyl)-
124-40-3 Dimethylamine Methanamine, N-methyl-
Long-chain 112-69-6 Hexadecyldimethylamine 1-Hexadecanamine, N, N-dimethyl- HTML Meets one or more of the criteria Refer to risk management scope
124-30-1 Octadecylamine 1-Octadecanamine
61788-46-3Table 1 Footnote b Cocoamine Amines, coco alkyl
61789-79-5Table 1 Footnote aTable 1 Footnote b Bis(hydrogenated tallow alkyl) amines (BHTAA) Amines, bis(hydrogenated tallow alkyl)
61790-59-8Table 1 Footnote b Hydrogenated tallow alkyl amines acetates (HTAAA) Amines, hydrogenated tallow alkyl, acetates
61790-60-1Table 1 Footnote b Tallow alkyl amines acetates (TAAA) Amines, tallow alkyl, acetates
61791-55-7Table 1 Footnote b N-tallow alkyltrimethylenediamines (TAPDA) Amines, N-tallow alkyltrimethylenedi-
68479-04-9Table 1 Footnote b 1,3-Propanediamine, N-[3-(tridecyloxy)propyl]-, branched (DPDAB) 1,3-Propanediamine, N-[3-(tridecyloxy)propyl]-, branched
68783-25-5Table 1 Footnote b N,N,N'-trimethyl-N'-tallow alkyltrimethylenediamines (TMTADA) Amines, N,N,N'-trimethyl-N'-tallow alkyltrimethylenedi-
Table 1 Footnote a

This substance was not identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999 (CEPA) but was included in this assessment as it was considered a priority on the basis of other human health concerns.

Table 1 Return to footnote a referrer

Table 1 Footnote b

This CAS RN is a UVCB (unknown or variable composition, complex reaction products, or biological materials).

Table 1 Return to footnote b referrer

Timelines
Date Activity
August 29, 2026 Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA.
June 24, 2023 Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA.
March 6, 2021 Publication and start of 60-day public comment period on the Draft Screening Assessment for the Aliphatic Amines Group and the Risk Management Scope for Long-chain Aliphatic Amines, including DPDAB. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 10.

Information gathering

Section 71 CMP 2026 – Phase 2

In August 2026, a notice was published in the Canada Gazette, Part I: Vol. 160, No. 35 – August 29, 2026, under section 71 of CEPA. This notice applies to nine substances included in this substance grouping (CAS RNs 112-69-6, 124-30-1, 61788-46-3, 61789-79-5, 61790-59-8, 61790-60-1, 61791-55-7, 68479-04-9, and 68783-25-5). More information is available on the information gathering with respect to certain substances under the CMP web page.

Section 71 CMP 2023

In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 – June 24, 2023 under section 71 of CEPA. This notice applies to 84 aliphatic amine substances. More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.

Background

Six other substances were identified as being a part of the Aliphatic Amines Group at the outset of the third phase of the CMP. Four of these six substances were subsequently determined to be of low concern to both human health and the environment, through other approaches. The conclusion for the substance with CAS RN 68955-53-3 is provided in the Final Screening Assessment for Substances Identified as Being of Low Concern based on the Ecological Risk Classification of Organic Substances and the Threshold of Toxicological Concern (TTC)-based Approach for Certain Substances. The conclusions for substances with CAS RNs 112-90-3, 80939-62-4 and 90367-27-4 are provided in the Final Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure. The remaining two substances (CAS RNs 108-91-8 and 58713-21-6) were moved from the Aliphatic Amines Group into the Sodium Cyclamate and Cyclohexylamine Group and the Hexamethylenetriamine Group, respectively.

Page details

2026-08-28

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us Chat on WhatsApp
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit